Chonluten
Lung and bronchial bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, swelling, or itching at the injection site may occur. Typically resolves within hours. Rotate injection sites to minimize recurrence. Apply ice if swelling persists.
Rash, urticaria, facial swelling, or difficulty breathing may indicate an allergic response. Discontinue use immediately and seek emergency medical attention if severe. Mild rash may be managed with antihistamines, but medical evaluation is recommended.
Mild headache may occur in the first few days of use. Usually self-resolving. Ensure adequate hydration and consider taking the dose in the evening if morning dosing triggers headaches.
May occur shortly after injection. Sit or lie down until symptoms resolve. If persistent, discontinue use and consult a healthcare provider.
Mild nausea may occur, particularly if injected on an empty stomach. Taking the dose with food or in the evening may reduce this effect.
Repeated injections at the same site can cause localized fat loss (lipoatrophy) or fat thickening (lipohypertrophy). Prevent by rotating injection sites systematically with each dose and spacing injections at least 1 inch apart.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mcg |
| Frequency | 1-2x daily |
| Timing | Morning and/or evening, sublingual or subcutaneous |
| Route | Subcutaneous |
Khavinson bioregulator peptide. Start at 10 mcg daily and assess tolerance. Limited Western clinical validation; primarily used in Russia and Eastern Europe. For research purposes only.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
Chonluten is a short-chain peptide bioregulator (2-4 amino acids) derived from lung and bronchial tissue that is proposed to regulate gene expression and support tissue-specific homeostasis in the respiratory system. The peptide is theorized to interact with cellular receptors and signaling pathways that promote normal lung function, tissue repair, and healthy inflammatory responses in the airways. Khavinson bioregulators are based on the hypothesis that tissue-derived peptides can restore organ-specific gene expression patterns and support regenerative processes.
Tissue-Specific Gene Regulation
Bioregulator peptides are proposed to bind to specific cellular receptors and modulate transcription factors that control lung and bronchial tissue-specific genes, supporting normal respiratory tissue function and repair.
Inflammatory Response Modulation
May influence cytokine signaling and immune cell activity in the respiratory tract to promote healthy inflammatory responses and tissue homeostasis.
Cellular Regeneration and Repair
Proposed to support fibroblast activity and epithelial cell renewal in lung tissue, potentially enhancing tissue repair mechanisms.
- Chonluten is part of the Khavinson bioregulator series, developed based on tissue-derived peptide research in Russia
- The exact amino acid sequence and molecular mechanism are not fully disclosed in peer-reviewed Western literature
- Bioregulator peptides are theorized to restore organ-specific gene expression patterns rather than act as traditional hormones or growth factors
- Clinical evidence in Western medical literature is limited; most published data originates from Russian and Eastern European research
Track your Chonluten research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Chonluten is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.